Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Oct 22;25(6):29.
doi: 10.1038/s41397-025-00388-9.

Evaluation of experiential teaching approaches to enhance pharmacy students' confidence and knowledge in pharmacogenomics

Affiliations

Evaluation of experiential teaching approaches to enhance pharmacy students' confidence and knowledge in pharmacogenomics

Ruby Soueid et al. Pharmacogenomics J. .

Abstract

Pharmacogenomic services are commonly pharmacist-led, yet pharmacists report poor knowledge and confidence in application. This study evaluated an experiential teaching approach to enhance students' confidence and knowledge in pharmacogenomics. Customised modules were delivered to three cohorts of second-year undergraduate pharmacy students. Cohort A received lectures and a tutorial; Cohort B added self-testing; Cohort C (same as B) added a case-based workshop and assignment. Students were predominantly female (64%) and half were younger than 20 years old. Self-perceived confidence, assessed using pre- and post-module surveys, significantly improved across all cohorts, in applying pharmacogenomic skills, recognising pharmacists' roles and perceptions towards self-testing. Students who self-tested in Cohort C reported greater confidence (e.g., "patient education testing risks": 26% test vs 0% no test). Knowledge, assessed using examination scores ranged from 70-74% across cohorts, showing no significant differences. Our findings suggest that experiential learning enhances confidence, supporting greater integration of pharmacogenomics into future practice.

PubMed Disclaimer

Conflict of interest statement

Competing interests: The authors declare no competing interests. Ethical approval and consent to participate: This study received ethical approval from The University of Sydney Human Research Ethics Committee (HREC 2022/250). All methods were performed in accordance with the guidelines set out in the National Statement on Ethical Conduct in Human Research. Students provided written informed consent and were assured that participation would not influence their grade.

References

    1. Young C, MacDougall D CADTH Horizon Scans. An Overview of Pharmacogenomic Testing for Psychiatric Disorders: CADTH Horizon Scan. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2023.
    1. Mathur S, Sutton J. Personalized medicine could transform healthcare. Biomed Rep. 2017;7:3–5. - PubMed - PMC - DOI
    1. Pearce A, Terrill B, Alffenaar JW, Patanwala AE, Kummerfeld S, Day R, et al. Pharmacogenomic testing: perception of clinical utility, enablers and barriers to adoption in Australian hospitals. Intern Med J. 2022;52:1135–43. - PubMed - PMC - DOI
    1. Jarrar Y, Musleh R, Hamdan A, Ghanim M, Alqub M, Abudahab S. Lack of exposure to pharmacogenomics education among the health care providing students in the West Bank of Palestine. Drug Metab Pers Ther. 2023;38:267–72. - PubMed - DOI
    1. Stanek EJ, Sanders CL, Taber KA, Khalid M, Patel A, Verbrugge RR, et al. Adoption of pharmacogenomic testing by US physicians: results of a nationwide survey. Clin Pharmacol Ther. 2012;91:450–8. - PubMed - DOI

LinkOut - more resources